Investigational Drug Information for L-Alanine
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug L-Alanine?
L-Alanine is an investigational drug.
There have been 11 clinical trials for L-Alanine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.
The most common disease conditions in clinical trials are Syndrome, Coronary Disease, and Coronary Artery Disease. The leading clinical trial sponsors are National Cancer Institute (NCI), Slocum Center for Orthopedics and Sports Medicine, and Nanjing Medical University.
There are one hundred and forty US patents protecting this investigational drug and two international patents.
Summary for L-Alanine
|US Patent Applications||257|
|WIPO Patent Applications||1|
|Japanese Patent Applications||0|
|Clinical Trial Progress||Phase 3 (2013-11-01)|
Recent Clinical Trials for L-Alanine
|Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V||Beijing Anzhen Hospital||N/A|
|Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Thymosin α1) V||Nanjing Medical University||N/A|
|Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19||National Cancer Institute (NCI)||Phase 2|
Clinical Trial Summary for L-Alanine
Top disease conditions for L-Alanine
Top clinical trial sponsors for L-Alanine
US Patents for L-Alanine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|L-Alanine||See Plans and Pricing||Synthetic polymeric drugs||Ceskoslovenska Akademie Ved (Praha, CS) Carlton Medical Products Limited (London, GB2)||See Plans and Pricing|
|L-Alanine||See Plans and Pricing||Substituted amino acid compounds||Adir et Compagnie (Courbevoie, FR)||See Plans and Pricing|
|L-Alanine||See Plans and Pricing||Solid phase peptide synthesis using a polyacrylic support in aqueous solution||Societe d'Expansion Scientifque Expansia (FR)||See Plans and Pricing|
|L-Alanine||See Plans and Pricing||Cyclic anticoagulant peptides||Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH)||See Plans and Pricing|
|L-Alanine||See Plans and Pricing||Amino nitrile intermediate for the preparation of alanine diacetic acid||The Dow Chemical Company (Midland, MI)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
International Patents for L-Alanine
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|L-Alanine||Austria||AT60991||2005-01-04||See Plans and Pricing|
|L-Alanine||Australia||AU5183386||2005-01-04||See Plans and Pricing|
|L-Alanine||Australia||AU589587||2005-01-04||See Plans and Pricing|
|L-Alanine||Canada||CA1305053||2005-01-04||See Plans and Pricing|
|L-Alanine||Germany||DE3581921||2005-01-04||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|